A registry program for familial gastric cancer patients referred to cancer institute of Iran

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 2141-2144

  Etemadi, Mehrnoosh ^a   Pourian, Mandana ^a   Shakib, Asyeh ^a   Sabokbar, Tayebeh ^b   Peyghanbari, Vahideh ^b   Shirkoohi, Reza ^b  

^a Students Scientific Research Center (SSRC) Exceptional Talent Development Center (ETDC)   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer institute; Cancer registry; Familial cancer; Gastric cancer; Including criteria

Indexed keywords

ADENOCARCINOMA; EARLY DIAGNOSIS; FAMILY; FEMALE; HUMAN; IRAN; MALE; MIDDLE AGED; ORGANIZATION; PROCEDURES; QUESTIONNAIRE; REGISTER; STOMACH NEOPLASMS;

ACADEMIES AND INSTITUTES; ADENOCARCINOMA; EARLY DETECTION OF CANCER; FAMILY; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; QUESTIONNAIRES; REGISTRIES; STOMACH NEOPLASMS;

EID: 84899104800     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.2141     Document Type: Article

References (29)

1. Al-Refaie W, Hu C, Pisters P, Chang G (2011). Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol, 18, 2800-7.
2. Barber M, Fitzgerald R, Caldas C (2006). Familial gastric cancer-aetiology and pathogenesis. Best Pract Res Clin Gastroenterol, 20, 721-34.
3. Behnampour N, HajizadehE, Zayeri F, Semnani S (2014). Modeling of influential predictors of gastric cancer incidence rates in Golestan province, North Iran. Asian Pac J Cancer Prev, 15, 1111-7.
4. Brose M, Smyrk T, Weber B, et al (1999). Familial gastric cancer: overview and guidelines for management. J Med Genet, 36, 873-80.
5. Chen Y, Kingham K, Ford J, et al (2011). A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol, 18, 2594-8.
6. Edgren G, Hjalgrim H, Rostgaard K, et al (2010). Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5.
7. Everatt R, Tamosiunas A, Kuzmickiene I, et al (2012).Alcohol consumption and risk of gastric cancer: a cohort study of men in Kaunas, Lithuania, with up to 30 years follow-up. BMC Cancer, 15, 475.
8. Goldman L, Schafer A (2012). Chapter 198. Neoplasms of the esophagus and stomach, Philadelphia: Elsvier Saunders.
9. Hajmanoochehri F, Mohammadi N, Nasirian N, Hosseinkhani M (2013). Patho-epidemiological features of esophageal and gastric cancers in an endemic region: a 20-year retrospective study. Asian Pac J Cancer Prev, 14, 3491-7.
10. Howlader N, Noone A, Krapcho M, et al (2011) (1975-2009 (Vintage 2009 Populations)) SEER Cancer Statistics Review. National Cancer Institute, Bethesda, MD.
11. Jacobs E, Thompson P, Martínez M (2007). Diet, gender, and colorectal neoplasia. J Clin Gastroenterol, 41, 731-46.
12. Jiang Y, Wan Y, Wang Z, et al (2004). Germline E-cadherin gene mutation screening in familial gastric cancer kindreds. Zhonghua Wai Ke Za Zhi, 42, 914-7.
13. Kang JM, Shin DW, Kwon YM, et al (2011). Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. World J Gastroenterol, 17, 3518-25.
14. Kato M, Asaka M (2012). Recent development of gastric cancer prevention. Jpn J Clin Oncol, 42, 987-94.
15. Kaurah P, Huntsman D (2011). Hereditary Diffuse Gastric Cancer. In: Pagon R, Bird T, Dolan C, Stephens K, Adam M, editors. GeneReviews. Seattle: University of Washington.
16. Keller G, Vogelsang H, Becker I, et al (1999). Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol, 155, 337-42.
17. Kolahdoozan S, Sadjadi A, Radmard A, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
18. Kumar EA (2010). Pathologic Basis of Disease. 8th ed.: Saunders Elsevier, 2010.
19. Mousavi S, Gouya M, Ramazani R, et al (2009) Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
20. Petrucelli N, Daly M, Feldman G (2011). BRCA1, BRCA2 Hereditary Breast and Ovarian Cancer In: Pagon R, Bird T, Dolan C, Stephens K, Adam M, editors. GeneReviews. Seattle University of Washington.
21. Richards F, McKee S, Rajpar M, et al (1999). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet, 8, 607-10.
22. Rustgi A (2012). Neoplasms of the Stomach. In: Goldman L, Ausiello D, editors. Cecil Medicine. 24 ed. Philadelphia, Pa: Saunders Elsevier. p. 1272-8.
23. Sabokbar T, Khajeh E, Taghdiri F, Peyghambari V, Shirkoohi R (2012). Familial breast cancer registry program in patients referred to the Cancer Institute of Iran. Asian Pac J Cancer Prev, 14, 2675-9.
24. Scheuner M, McNeel T, Freedman A (2010). Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med, 12, 726-35.
25. Strnad M (2010). Salt and cancer. Acta Med Croatica, 64, 159-61.
26. Wang X, Terry P, Yan H (2010). Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol, 15, 204-13.
27. Winawer S (2005). Gastric cancer: Worldwide burden and prevention opportunities. Chin J Dig Dis, 6, 107-9.
28. Zare A, Mahmoodi M, Mohammad K, et al (2013). Survival analysis of patients with gastric cancer undergoing surgery at the Iran Cancer Institute: a method based on multi-state models. Asian Pac J Cancer Prev, 14, 6369-73.
29. Zhang Y, Shi J, Yu H, et al (2012). Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol, 18, 3602-9.